Search Results

ANCHOR Postmarket Registry Data Presented for Aptus's Heli-FX EndoAnchor EVAR System

October 8, 2013—Aptus Endosystems, Inc. (Sunnyvale, CA) announced initial results from its ANCHOR postmarket registry evaluating the use of the company's Heli-FX EndoAnchor system in endovascular aneurysm repair (EVAR).

NuCryo Vascular to Take Over Manufacturing and Marketing of PolarCath Cryoplasty System

November 16, 2015—Vascular Solutions, Inc. and NuCryo Vascular, LLC announced that they have mutually terminated the agreement under which Vascular Solutions has been serving as exclusive distributor of the PolarCath peripheral dilatation system in the United States.

NuCryo Vascular's PolarCath Peripheral Balloon Dilatation System to Be Distributed by Lokai Medical

August 9, 2018—NuCryo Vascular LLC announced that the company has signed a commercialization agreement with Lokai Medical to distribute the PolarCath balloon dilatation system in the United States.

Vascular Solutions Launches PolarCath Peripheral Dilatation System in United States

March 16, 2015—Vascular Solutions, Inc. announced that it has commenced sales of the PolarCath peripheral dilatation system in the United States in collaboration with the product’s manufacturer, NuCryo Vascular LLC. The PolarCath system is indicated for use in dilating stenosis in the peripheral vasculature (iliac, femoral, popliteal, infrapopliteal, renal, and subclavian arteries) and for the treatment of obstructive lesions of polytetrafluoroethylene access grafts or arteriovenous dialysis fistulas.

Early Findings Presented for PQ Bypass' Endovascular Femoropopliteal Artery Bypass Procedure

September 14, 2016—PQ Bypass, Inc., which is developing a fully percutaneous approach (the PQ Detour procedure) to femoropopliteal bypass surgery, announced that early results of a study using the PQ bypass system were presented by Piotr Szopiński, MD, at CIRSE 2016, the annual meeting of the Cardiovascular and Interventional Radiology Society of Europe annual meeting in Barcelona, Spain.

FDA Clears NuCryo Vascular's Next-Generation Reusable Cryoplasty Inflation Device

January 4, 2016—NuCryo Vascular LLC announced that the company has received US Food and Drug Administration 510(k) clearance for the next-generation reusable Cryoplasty inflation device.

Vascular Solutions to Distribute PolarCath Peripheral Dilatation System

November 4, 2014—Vascular Solutions, Inc. announced that it has entered into an agreement with NuCryoVascular LLC under which Vascular Solutions will serve as exclusive distributor of the PolarCath peripheral dilatation system in the United States.

Vascular Solutions Announces Launch of 0.035-Inch Catheters for PolarCath System

August 3, 2015—Vascular Solutions, Inc. announced the expansion of the PolarCath peripheral dilatation system product line with the launch of 11 versions of the 0.035-inch guidewire-compatible balloon catheters, which are manufactured by NuCryo Vascular LLC. In November 2014, Vascular Solutions announced an agreement with NuCryo to serve as the exclusive United States distributor of the PolarCath product line.

First Patients Enrolled in Pivotal DETOUR II Trial

February 22, 2018—PQ Bypass announced enrollment of the first patients in the pivotal DETOUR II trial in the United States.